Reuters logo
in 7 months
BRIEF-Yichang Hec Changjiang Pharmaceutical Co enters capital increase agreement with parent co
December 16, 2016 / 1:33 PM / in 7 months

BRIEF-Yichang Hec Changjiang Pharmaceutical Co enters capital increase agreement with parent co

1 Min Read

Dec 16 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd

* Parent company shall transfer total consideration of rmb19.3mln

* Company and parent company entered into capital increase agreement

* Parent company has agreed to subscribe in cash for, an aggregate of 1.2 million new domestic shares at rmb16.12 per new domestic share

* Company could use proceeds from proposed subscription to further develop its business

* Proceeds from issue of new domestic shares are expected to be approximately rmb19.3 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below